Cargando…

Current status and considerations on biosimilar in China

Detalles Bibliográficos
Autor principal:	Wang, Junzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479963/ http://dx.doi.org/10.1186/1479-5876-10-S2-A38

Ejemplares similares

Biosimilar drugs: Current status
por: Kumar, Rajiv, et al.
Publicado: (2014)

Regulatory Considerations for Biosimilars
por: Nellore, Ranjani
Publicado: (2010)

Current Status of Biosimilar Growth Hormone
por: Saenger, Paul
Publicado: (2009)

Current status of maintenance hemodialysis in Beijing, China
por: Zuo, Li, et al.
Publicado: (2013)

The development of guidelines for management of thyroid diseases in pregnancy – current status
por: Hubalewska-Dydejczyk, Alicja, et al.
Publicado: (2015)

Pharmacovigilance Considerations for Biosimilars in the USA
por: Grampp, Gustavo, et al.
Publicado: (2015)

Clinical considerations for biosimilar antibodies
por: Mellstedt, Håkan
Publicado: (2013)

Biosimilars in India; Current Status and Future Perspectives
por: Meher, Bikash R., et al.
Publicado: (2019)

The biosimilars journey: current status and ongoing challenges
por: Kos, Igor Age, et al.
Publicado: (2018)

Challenges of Integrating Biosimilars Into Clinical Practice
por: Jeffers, Kate, et al.
Publicado: (2020)

Considerations on the late-preterm newborn with cardiac problems
por: Fiocchi, S
Publicado: (2014)

Biosimilars in oncology and inflammatory diseases: current and future considerations for clinicians in Latin America
por: Scheinberg, Morton, et al.
Publicado: (2018)

Clinical considerations for the development of biosimilars in oncology
por: Socinski, Mark A, et al.
Publicado: (2015)

Current status of biosimilars in the treatment of inflammatory bowel diseases
por: Park, Dong Il
Publicado: (2016)

Considerable differences in the utilisation of antidiabetics between Serbia and Scandinavian countries
por: Pavlović, Nebojša, et al.
Publicado: (2012)

Treatment of Jehovah’s witness patients. Surgical and medico-legal considerations
por: Terranova, C, et al.
Publicado: (2011)

Design considerations for massively parallel sequencing studies of common familial cancers
por: Feng, BJ, et al.
Publicado: (2012)

Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
por: Mysler, Eduardo, et al.
Publicado: (2021)

Regulatory considerations in oncologic biosimilar drug development
por: Macdonald, Judith C, et al.
Publicado: (2015)

Practical Considerations for Integrating Biosimilars Into Clinical Practice
por: May, Megan B., et al.
Publicado: (2021)

Current perspectives on biosimilars
por: Agbogbo, Frank K., et al.
Publicado: (2019)

Key considerations for a pre-emergency survival pack: a hypothetical case study
por: Khah, Alvin, et al.
Publicado: (2015)

Pharmacodynamic Biomarkers Evidentiary Considerations for Biosimilar Development and Approval
por: Strauss, David G., et al.
Publicado: (2022)

Anxiety and depression in family members of ICU patients: ethical considerations regarding decision-making capacity
por: Pochard, F, et al.
Publicado: (2000)

Biosimilars: Key regulatory considerations and similarity assessment tools
por: Kirchhoff, Carol F., et al.
Publicado: (2017)

Cultural considerations: alcohol screening and brief intervention in a southern US level-1 trauma center
por: Veach, Laura, et al.
Publicado: (2012)

Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseases
por: Park, Sang Hyoung, et al.
Publicado: (2020)

Biosimilars 101: considerations for U.S. oncologists in clinical practice
por: Camacho, Luis H, et al.
Publicado: (2014)

Biosimilars in the United States: Considerations for Oncology Advanced Practitioners
por: Mayden, Kelley D., et al.
Publicado: (2015)

Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
por: Francescon, Sara, et al.
Publicado: (2016)

Biosimilars in Pediatric IBD: Updated Considerations for Disease Management
por: Dipasquale, Valeria, et al.
Publicado: (2022)

Current concepts in hand infections
por: Turker, Tolga
Publicado: (2015)

Thumb hypoplasia: current concepts
por: Tonkin, Michael
Publicado: (2015)

Hypothermia in refractory status epilepticus
por: Rossetti, Andrea O
Publicado: (2012)

Probiotics: current evidences and new perspectives
por: Fabiano, Valentina, et al.
Publicado: (2014)

Proceedings of the 2016 China Cancer Immunotherapy Workshop: Beijing, China. 25-26 June 2016
por: Xue, Bin, et al.
Publicado: (2016)

Online Behavioral Addictions in 2023: An Overview and Current Considerations
por: Potenza, M. N.
Publicado: (2023)

A strategic thinking of the scientific system of drug regulatory in China - advancing drug standards of China
por: Zhou, Fucheng
Publicado: (2012)

Psychological status and breath at children with psychosomatic pathology
por: Grishin, Oleg, et al.
Publicado: (2010)

Considerations for the US health-system pharmacist in a world of biosimilars
por: Zlatkus, Andrea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_td7sfl5ftirsql2vp8o19572jt